STATE OF NEW YORK ________________________________________________________________________ 4141--A 2023-2024 Regular Sessions IN ASSEMBLY February 10, 2023 ___________ Introduced by M. of A. FORREST, RAGA, GALLAGHER, SHRESTHA, GONZALEZ-RO- JAS, ARDILA, ALVAREZ, DARLING, AUBRY, SIMON, COLTON, BURDICK, MAMDANI, CHANDLER-WATERMAN, MITAYNES, MEEKS, STECK, KELLES, BLUMENCRANZ, DeSTE- FANO, WALKER, SEPTIMO, TAPIA, TAYLOR, THIELE, ANDERSON, TAGUE, BENDETT, HYNDMAN, DICKENS, DURSO, SIMONE, EPSTEIN, CRUZ, DAVILA, COOK, SHIMSKY, LUNSFORD, BORES, CURRAN, LEVENBERG, FLOOD, MAHER, JACOBSON, BURGOS, HUNTER, CUNNINGHAM, RAJKUMAR, CARROLL, SANTABARBARA, JACKSON, CLARK, REYES -- read once and referred to the Committee on Insurance -- recommitted to the Committee on Insurance in accordance with Assem- bly Rule 3, sec. 2 -- committee discharged, bill amended, ordered reprinted as amended and recommitted to said committee AN ACT to amend the insurance law, in relation to prohibiting cost shar- ing for insulin The People of the State of New York, represented in Senate and Assem- bly, do enact as follows: 1 Section 1. Subparagraph (B) of paragraph 15-a of subsection (i) of 2 section 3216 of the insurance law, as amended by section 1 of part DDD 3 of chapter 56 of the laws of 2020, is amended to read as follows: 4 (B) Such coverage may be subject to annual deductibles and coinsurance 5 as may be deemed appropriate by the superintendent and as are consistent 6 with those established for other benefits within a given policy; 7 provided however, [the total amount] that [a covered person is required 8 to pay out of pocket for] covered prescription insulin drugs shall [be 9 capped at an amount not to exceed one hundred dollars per thirty-day 10 supply, regardless of the amount or type of insulin needed to fill such 11 covered person's prescription and regardless of the insured's] not be 12 subject to a deductible, copayment, coinsurance or any other cost shar- 13 ing requirement. 14 § 2. Subparagraph (B) of paragraph 7 of subsection (k) of section 3221 15 of the insurance law, as amended by section 2 of part DDD of chapter 56 16 of the laws of 2020, is amended to read as follows: EXPLANATION--Matter in italics (underscored) is new; matter in brackets [ ] is old law to be omitted. LBD02649-03-4
A. 4141--A 2 1 (B) Such coverage may be subject to annual deductibles and coinsurance 2 as may be deemed appropriate by the superintendent and as are consistent 3 with those established for other benefits within a given policy; 4 provided however, [the total amount] that [a covered person is required 5 to pay out of pocket for] covered prescription insulin drugs shall [be 6 capped at an amount not to exceed one hundred dollars per thirty-day 7 supply, regardless of the amount or type of insulin needed to fill such 8 covered person's prescription and regardless of the insured's] not be 9 subject to a deductible, copayment, coinsurance or any other cost shar- 10 ing requirement. 11 § 3. Paragraph 2 of subsection (u) of section 4303 of the insurance 12 law, as amended by section 3 of part DDD of chapter 56 of the laws of 13 2020, is amended to read as follows: 14 (2) Such coverage may be subject to annual deductibles and coinsurance 15 as may be deemed appropriate by the superintendent and as are consistent 16 with those established for other benefits within a given policy; 17 provided however, [the total amount] that [a covered person is required 18 to pay out of pocket for] covered prescription insulin drugs shall [be 19 capped at an amount not to exceed one hundred dollars per thirty-day 20 supply, regardless of the amount or type of insulin needed to fill such 21 covered person's prescription and regardless of the insured's] not be 22 subject to a deductible, copayment, coinsurance or any other cost shar- 23 ing requirement. 24 § 4. This act shall take effect January 1, 2025 and shall apply to any 25 policy or contract issued, renewed, modified, altered, or amended on or 26 after such date.